Diabetic Cardiomyopathy: 2023 Update by the International Multidisciplinary Board of Experts-Reference-Cited by-同舟云学术

Diabetic Cardiomyopathy: 2023 Update by the International Multidisciplinary Board of Experts

Published:2024-01 Issue:1 Volume:49 Page:102052
ISSN:0146-2806
Container-title:Current Problems in Cardiology
language:en
Short-container-title:Current Problems in Cardiology

Author:

Avagimyan Ashot^ORCID,Fogacci Federica,Pogosova Nana,Kakrurskiy Lev,Kogan Eugenia,Urazova Olga,Kobalava Zhanna,Mikhaleva Liudmila,Vandysheva Rositsa,Zarina Gioeva,Trofimenko Artem,Navasardyan Grizelda,Mkrtchyan Lusine,Galli Mattia,Jndoyan Zinaida,Aznauryan Anait,Saahakyan Karmen,Agati Luciano,Shafie Davood,Cicero Arrigo,Salvo Giovanni Di,Sarrafzadegan Nizal

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference93 articles.

1. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease;Jia;Diabetologia,2018

2. Diabetes mellitus and heart failure;Lehrke;Am J Med,2017

3. Type 2 diabetes mellitus and heart failure: a Scientific Statement from the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update;Dunlay;Circulation,2019

4. Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities;Cuijpers;Basic Res Cardiol,2020

5. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: a Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Heidenreich;Circulation,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Cardioprotective Effects of Dapagliflozin and Trimetazidine in the Model of Doxorubicin-Cyclophosphamide Cardiotoxicity;Innovative Medicine of Kuban;2023-11-15

2. Visualizing the Role of ER Stress in Diabetic Cardiomyopathy: A Bibliometric Analysis;2023